WILEY The inhibition of pathological protein-protein interactions is a promising approach for treating a large number of diseases, including many forms of cancer. A team of researchers has now developed a bicyclic peptide that binds to beta-catenin–a protein associated with certain types of tumor. The secret of their success is the cyclic nature and the...